We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-5.85%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$35.2B
AUM Growth
-$3.94B
Cap. Flow
-$1.12B
Cap. Flow %
-3.19%
Top 10 Hldgs %
20.4%
Holding
1,273
New
111
Increased
414
Reduced
514
Closed
94

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$63.8M
2
ALGN icon
Align Technology
ALGN
+$61.4M
3
STLA icon
Stellantis
STLA
+$54.4M
4
UBS icon
UBS Group
UBS
+$49.7M
5
RSG icon
Republic Services
RSG
+$44M

Top Sells

Rank Stock Value
1
RACE icon
Ferrari
RACE
+$73.1M
2
IPGP icon
IPG Photonics
IPGP
+$62.1M
3
ADBE icon
Adobe
ADBE
+$61.1M
4
UNH icon
UnitedHealth
UNH
+$56.3M
5
AAPL icon
Apple
AAPL
+$54.5M

Sector Composition

Rank Sector Weight
1 Technology 29.78%
2 Healthcare 17.08%
3 Financials 11.22%
4 Consumer Discretionary 10.87%
5 Industrials 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEO icon
1126
The GEO Group
GEO
$4B
$95.2K ﹤0.01%
14,400
-30,100
-68% -$197K
TAL icon
1127
TAL Education Group
TAL
$6.04B
$90.4K ﹤0.01%
30,045
MOMO
1128
Hello Group
MOMO
$867M
$70.2K ﹤0.01%
12,146
+3,046
+33% +$26.4K
QVCGA
1129
DELISTED
QVC Group Inc Series A
QVCGA
$63.8K ﹤0.01%
268
-1,260
-82% -$402K
YRD
1130
Yiren Digital
YRD
$93.6M
$62.7K ﹤0.01%
24,700
SBS icon
1131
Sabesp
SBS
$18.4B
$57.4K ﹤0.01%
30,124
LXRX icon
1132
Lexicon Pharmaceuticals
LXRX
$1.03B
$43.7K ﹤0.01%
20,900
-54,300
-72% -$151K
MRSN
1133
DELISTED
Mersana Therapeutics
MRSN
$43.1K ﹤0.01%
432
-5,488
-93% -$641K
CLVS
1134
DELISTED
Clovis Oncology, Inc.
CLVS
$41.6K ﹤0.01%
20,600
-380,700
-95% -$748K
AGEN
1135
Agenus
AGEN
$276M
-12,452
Closed -$787K
ALKT icon
1136
Alkami Technology
ALKT
$1.96B
-406,677
Closed -$8.16M
APD icon
1137
Air Products & Chemicals
APD
$65.5B
-30,440
Closed -$9.26M
AZN icon
1138
AstraZeneca
AZN
$269B
-304
Closed -$35K
AZTA icon
1139
Azenta
AZTA
$1.3B
-18,300
Closed -$1.89M
BLD
1140
DELISTED
TopBuild
BLD
-1,500
Closed -$414K
BPMC
1141
DELISTED
Blueprint Medicines
BPMC
-89,521
Closed -$9.59M
BRC icon
1142
Brady Corp
BRC
$4.46B
-31,700
Closed -$1.71M
BSBR icon
1143
Santander
BSBR
$38.2B
-5,164
Closed -$28K
BURL icon
1144
Burlington
BURL
$23.4B
-714
Closed -$208K
BYD icon
1145
Boyd Gaming
BYD
$6.75B
-12,700
Closed -$833K
CALX icon
1146
Calix
CALX
$2.24B
-53,100
Closed -$4.25M
CGNT icon
1147
Cognyte Software
CGNT
$655M
-73,295
Closed -$1.15M
CRD.B icon
1148
Crawford & Co Class B
CRD.B
$507M
-16,600
Closed -$124K
CUZ icon
1149
Cousins Properties
CUZ
$5.31B
-11,198
Closed -$451K
CWH icon
1150
Camping World
CWH
$384M
-90,100
Closed -$3.64M

Similar funds

Axa's Q1 2022 Portfolio in Review

As of Q1 2022, Axa held 1,273 positions worth $35.2B, down 10% from $39.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Axa withdrew a net $1.12B in Q1 2022, closing 94 positions and reducing 514 holdings. Its most notable exit was Zai Lab, an estimated $21.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Axa opened a new position in Freshpet worth $30.3M.

  • Axa's largest Q1 2022 buy was Freshpet: 294,939 shares worth $30.3M.
  • Axa added most to Pfizer in Q1 2022, an estimated $63.8M increase.
  • Axa's biggest Q1 2022 reduction was Ferrari, cutting an estimated $73.1M.
  • Axa fully exited Zai Lab in Q1 2022, selling an estimated $21.3M.
  • Axa's ten largest holdings make up 20% of its $35.2B portfolio in Q1 2022.
  • Axa opened 111 new positions and closed 94 in Q1 2022.
  • Axa's portfolio value fell 10% quarter-over-quarter to $35.2B.

Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.